Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases-Reference-Cited by-同舟云学术

Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases

Published:2015-08-06 Issue:5 Volume:23 Page:231-269
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacol

Author:

Rainsford K. D.,Parke Ann L.,Clifford-Rashotte Matthew,Kean W. F.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/s10787-015-0239-y.pdf

Reference388 articles.

1. Abdel-Hamid H, Oddis CV, Lacomis D (2008) Severe hydroxychloroquine myopathy. Muscle Nerve 38:1206–1210

2. Abou-Raya S et al. (2014) Efficacy of hydroxychloroquine in the treatment of symptomatic knee osteoarthritis in older adults: a randomized placebo-controlled trial. Ann Rheum Dis 73:756–757

3. Acha-Orbea H, Groscurth P, Lang R, Stitz J, Hengartner H (1983) Characterization of cloned cytotoxic lymphocytes with NK-like activity. J Immunol 130:2952–2959

4. Achuthan S, Ahluwalia J, Shafig N, Pareek A, Chandurkar N, Malhotra S (2015) Hydroxychloroquine’s efficacy as an antiplatelet agent study in healthy volunteers: a proof of concept study. J Cardiovasc Pharmacol Ther 20:174–180

5. Ackerman NR, Jubb S, Marlowe SL (1981) Effects of various anti-inflammatory and anti-rheumatic agents on the synthesis, secretion and activity of a cartilage proteoglycan-degrading enzyme and other macrophage enzymes. Biochem Pharmacol 30:2147–2155

Cited by 431 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation of Fe-doped coffee ground biochar and activation of PMS for chloroquine phosphate removal;Applied Surface Science;2025-01

2. Chloroquine: Rapidly withdrawing from first-line treatment of COVID-19;Heliyon;2024-09

3. Challenges and Reflections on Pandemic Disinformation: The Case of Hydroxychloroquine and the Implications for Global Public Health;Value in Health Regional Issues;2024-09

4. Hospitalization after hydroxychloroquine initiation in patients with heart failure with preserved ejection fraction and autoimmune disease;Journal of Internal Medicine;2024-08-28

5. Association between geniquin therapy and the risk of developing periodontal disease in patients with primary Sjögren’s syndrome: A population-based cohort study from Taiwan;PLOS ONE;2024-08-07